The company believes that growth reflects an evolving product profile responsive to health needs, vitality and strengthening the lives of its consumers.

Nestor is manufacturing and marketing a wide range of Pharmaceutical formulations in different therapeutic groups including Cardiovascular, Anti Diabetic, Anti-Malarial, Anti allergic, Anti-Diarrheal, Anti TB, Anti Inflammatory, Anti-Depressant, Multi Vitamins, Antacid, Analgesic, Anti-Pyretic, Antibiotics, Cough & Cold, Pain Management, Muscle Relaxant etc. The existing product portfolio consists of more than 400 licensed brands in the form of Tablets, Capsules, Injectable, Syrups / Suspension, Ointments, Dry Powder, Ear/ Eye Drops representing a range of clinically proven products developed from scientifically validated and licensed products.

Nestor is exporting or is under registration for exporting its branded / generic medicines to a large number of overseas countries. In order to ensure quick and prompt registrations, the company has its own DRA Department (Drug Regulatory Affairs) having experienced and knowledgeable personnel well versed with regulatory requirements of different countries. The large number of product registrations and application for registrations is the core strength ofNestor’s future in exports.

Mr. Prashant Sehgal, President monitors export SBU which is registering exponential growth every year. An erudite personality with vast experience of export business, Mr. Sehgal’s vision and foresight on the potential of global healthcare market has propelled Nestor to higher pedestals of growth and expansion in global trade. Today, export operations are significantly contributing to the top and bottom line of the company.